GoldenGolden

AM Pharma

AM-Pharma is a biopharmaceutical company developing recombinant human Alkaline Phosphatase (AP) therapeutics, which have the potential to treat patients with Acute Kidney Injury, Inflammatory Bowel Disease and Hypophosphatasia.

Previously, the company developed and tested a bovine form of AP in three phase II trials in patients with sepsis, AKI and UC.AM-Pharma has since developed and manufactured a proprietary and fully human recombinant form of AP, known as recAP.

Timeline

September 13, 2011
AM Pharma raises a $39,843,400 series D round from Abbott Laboratories, BB Biotech Ventures, Forbion Capital Partners, IDInvest Partners, Inventages Venture Capital Investment Inc., Kurma Life Science Partners, Shire and Ysios Capital.

Funding rounds

Funding round
Funding type
Funding round amount (USD)
Funding round date
Investment
AM Pharma Series D round
39,843,400
September 13, 2011
2 Results
Results per page:
Page 1 of 1

People

Name
Role
LinkedIn

Further reading

Title
Author
Link
Type
Date

Documentaries, videos and podcasts

Title
Date
Link

Companies

Company
CEO
Location
Products/Services

References

Golden logo
Text is available under the Creative Commons Attribution-ShareAlike 4.0; additional terms apply. By using this site, you agree to our Terms & Conditions.